Shares of Transcat, Inc. (NASDAQ:TRNS) have been given a consensus broker rating score of 2.00 (Buy) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a buy rating. Transcat’s rating score has declined by 33.3% in the last three months as a result of various analysts’ upgrades and downgrades.

Analysts have set a one year consensus price objective of $32.00 for the company and are predicting that the company will post $0.19 earnings per share for the current quarter, according to Zacks. Zacks has also given Transcat an industry rank of 240 out of 256 based on the ratings given to its competitors.

TRNS has been the subject of a number of recent analyst reports. ValuEngine cut Transcat from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Zacks Investment Research cut Transcat from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 30th.

Transcat stock traded down $1.22 during trading hours on Friday, reaching $22.13. 27,700 shares of the company were exchanged, compared to its average volume of 32,655. The firm has a market cap of $170.59 million, a price-to-earnings ratio of 23.29, a PEG ratio of 3.17 and a beta of 0.72. The company has a current ratio of 2.10, a quick ratio of 1.38 and a debt-to-equity ratio of 0.44. The stock has a 50-day moving average of $24.24 and a 200 day moving average of $24.08. Transcat has a 12 month low of $17.56 and a 12 month high of $27.00.

Transcat (NASDAQ:TRNS) last announced its earnings results on Tuesday, July 23rd. The scientific and technical instruments company reported $0.23 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.02). The company had revenue of $42.40 million for the quarter. Transcat had a return on equity of 12.84% and a net margin of 4.46%. As a group, research analysts forecast that Transcat will post 0.92 EPS for the current year.

In other news, Director Carl E. Sassano sold 5,000 shares of the stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $24.85, for a total value of $124,250.00. Following the completion of the sale, the director now directly owns 71,484 shares of the company’s stock, valued at $1,776,377.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Chairman Charles P. Hadeed sold 10,000 shares of the stock in a transaction that occurred on Tuesday, June 18th. The shares were sold at an average price of $26.50, for a total value of $265,000.00. Following the completion of the sale, the chairman now directly owns 50,993 shares of the company’s stock, valued at $1,351,314.50. The disclosure for this sale can be found here. Insiders have sold 33,462 shares of company stock valued at $842,642 in the last ninety days. Company insiders own 8.90% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. raised its stake in shares of Transcat by 1,477.5% in the second quarter. BlackRock Inc. now owns 366,492 shares of the scientific and technical instruments company’s stock valued at $9,378,000 after purchasing an additional 343,259 shares in the last quarter. Punch & Associates Investment Management Inc. raised its stake in shares of Transcat by 0.8% in the first quarter. Punch & Associates Investment Management Inc. now owns 340,398 shares of the scientific and technical instruments company’s stock valued at $7,822,000 after purchasing an additional 2,700 shares in the last quarter. Wasatch Advisors Inc. raised its stake in shares of Transcat by 16.5% in the first quarter. Wasatch Advisors Inc. now owns 323,971 shares of the scientific and technical instruments company’s stock valued at $7,445,000 after purchasing an additional 45,878 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Transcat by 12.3% in the second quarter. Vanguard Group Inc. now owns 298,719 shares of the scientific and technical instruments company’s stock valued at $7,644,000 after purchasing an additional 32,636 shares in the last quarter. Finally, Ancora Advisors LLC raised its stake in shares of Transcat by 22.0% in the second quarter. Ancora Advisors LLC now owns 268,160 shares of the scientific and technical instruments company’s stock valued at $6,862,000 after purchasing an additional 48,368 shares in the last quarter. 60.71% of the stock is owned by institutional investors.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Featured Article: The risks of owning bonds

Get a free copy of the Zacks research report on Transcat (TRNS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.